352 related articles for article (PubMed ID: 31323433)
1. Repeat-associated RNA structure and aberrant splicing.
Hale MA; Johnson NE; Berglund JA
Biochim Biophys Acta Gene Regul Mech; 2019; 1862(11-12):194405. PubMed ID: 31323433
[TBL] [Abstract][Full Text] [Related]
2. The regulation properties of RNA secondary structure in alternative splicing.
Bartys N; Kierzek R; Lisowiec-Wachnicka J
Biochim Biophys Acta Gene Regul Mech; 2019; 1862(11-12):194401. PubMed ID: 31323437
[TBL] [Abstract][Full Text] [Related]
3. Short Tandem Repeat Expansions and RNA-Mediated Pathogenesis in Myotonic Dystrophy.
Sznajder ŁJ; Swanson MS
Int J Mol Sci; 2019 Jul; 20(13):. PubMed ID: 31323950
[TBL] [Abstract][Full Text] [Related]
4. Pseudouridine Modification Inhibits Muscleblind-like 1 (MBNL1) Binding to CCUG Repeats and Minimally Structured RNA through Reduced RNA Flexibility.
deLorimier E; Hinman MN; Copperman J; Datta K; Guenza M; Berglund JA
J Biol Chem; 2017 Mar; 292(10):4350-4357. PubMed ID: 28130447
[TBL] [Abstract][Full Text] [Related]
5. Colocalization of muscleblind with RNA foci is separable from mis-regulation of alternative splicing in myotonic dystrophy.
Ho TH; Savkur RS; Poulos MG; Mancini MA; Swanson MS; Cooper TA
J Cell Sci; 2005 Jul; 118(Pt 13):2923-33. PubMed ID: 15961406
[TBL] [Abstract][Full Text] [Related]
6. An engineered RNA binding protein with improved splicing regulation.
Hale MA; Richardson JI; Day RC; McConnell OL; Arboleda J; Wang ET; Berglund JA
Nucleic Acids Res; 2018 Apr; 46(6):3152-3168. PubMed ID: 29309648
[TBL] [Abstract][Full Text] [Related]
7. (CTG)n repeat-mediated dysregulation of MBNL1 and MBNL2 expression during myogenesis in DM1 occurs already at the myoblast stage.
André LM; van Cruchten RTP; Willemse M; Wansink DG
PLoS One; 2019; 14(5):e0217317. PubMed ID: 31116797
[TBL] [Abstract][Full Text] [Related]
8. MBNL proteins and their target RNAs, interaction and splicing regulation.
Konieczny P; Stepniak-Konieczna E; Sobczak K
Nucleic Acids Res; 2014; 42(17):10873-87. PubMed ID: 25183524
[TBL] [Abstract][Full Text] [Related]
9. Gain of RNA function in pathological cases: Focus on myotonic dystrophy.
Klein AF; Gasnier E; Furling D
Biochimie; 2011 Nov; 93(11):2006-12. PubMed ID: 21763392
[TBL] [Abstract][Full Text] [Related]
10. Mechanistic determinants of MBNL activity.
Sznajder ŁJ; Michalak M; Taylor K; Cywoniuk P; Kabza M; Wojtkowiak-Szlachcic A; Matłoka M; Konieczny P; Sobczak K
Nucleic Acids Res; 2016 Dec; 44(21):10326-10342. PubMed ID: 27733504
[TBL] [Abstract][Full Text] [Related]
11. Combinatorial regulation of alternative splicing.
Shenasa H; Hertel KJ
Biochim Biophys Acta Gene Regul Mech; 2019; 1862(11-12):194392. PubMed ID: 31276857
[TBL] [Abstract][Full Text] [Related]
12. Muscleblind isoforms are functionally distinct and regulate alpha-actinin splicing.
Vicente M; Monferrer L; Poulos MG; Houseley J; Monckton DG; O'dell KM; Swanson MS; Artero RD
Differentiation; 2007 Jun; 75(5):427-40. PubMed ID: 17309604
[TBL] [Abstract][Full Text] [Related]
13. Muscleblind-like 1 interacts with RNA hairpins in splicing target and pathogenic RNAs.
Yuan Y; Compton SA; Sobczak K; Stenberg MG; Thornton CA; Griffith JD; Swanson MS
Nucleic Acids Res; 2007; 35(16):5474-86. PubMed ID: 17702765
[TBL] [Abstract][Full Text] [Related]
14. Short antisense-locked nucleic acids (all-LNAs) correct alternative splicing abnormalities in myotonic dystrophy.
Wojtkowiak-Szlachcic A; Taylor K; Stepniak-Konieczna E; Sznajder LJ; Mykowska A; Sroka J; Thornton CA; Sobczak K
Nucleic Acids Res; 2015 Mar; 43(6):3318-31. PubMed ID: 25753670
[TBL] [Abstract][Full Text] [Related]
15. Small non-coding RNA within the endogenous spliceosome and alternative splicing regulation.
Sperling R
Biochim Biophys Acta Gene Regul Mech; 2019; 1862(11-12):194406. PubMed ID: 31323432
[TBL] [Abstract][Full Text] [Related]
16. Circular exonic RNAs: When RNA structure meets topology.
Pervouchine DD
Biochim Biophys Acta Gene Regul Mech; 2019; 1862(11-12):194384. PubMed ID: 31102674
[TBL] [Abstract][Full Text] [Related]
17. Molecular mechanisms responsible for aberrant splicing of SERCA1 in myotonic dystrophy type 1.
Hino S; Kondo S; Sekiya H; Saito A; Kanemoto S; Murakami T; Chihara K; Aoki Y; Nakamori M; Takahashi MP; Imaizumi K
Hum Mol Genet; 2007 Dec; 16(23):2834-43. PubMed ID: 17728322
[TBL] [Abstract][Full Text] [Related]
18. Furamidine Rescues Myotonic Dystrophy Type I Associated Mis-Splicing through Multiple Mechanisms.
Jenquin JR; Coonrod LA; Silverglate QA; Pellitier NA; Hale MA; Xia G; Nakamori M; Berglund JA
ACS Chem Biol; 2018 Sep; 13(9):2708-2718. PubMed ID: 30118588
[TBL] [Abstract][Full Text] [Related]
19. Alternative splicing in lung cancer.
Coomer AO; Black F; Greystoke A; Munkley J; Elliott DJ
Biochim Biophys Acta Gene Regul Mech; 2019; 1862(11-12):194388. PubMed ID: 31152916
[TBL] [Abstract][Full Text] [Related]
20. MBNL Sequestration by Toxic RNAs and RNA Misprocessing in the Myotonic Dystrophy Brain.
Goodwin M; Mohan A; Batra R; Lee KY; Charizanis K; Fernández Gómez FJ; Eddarkaoui S; Sergeant N; Buée L; Kimura T; Clark HB; Dalton J; Takamura K; Weyn-Vanhentenryck SM; Zhang C; Reid T; Ranum LP; Day JW; Swanson MS
Cell Rep; 2015 Aug; 12(7):1159-68. PubMed ID: 26257173
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]